Benedic Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 27-06-2024
- Paid Up Capital ₹ 1.20 M
as on 27-06-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.54 Cr
as on 27-06-2024
- Revenue 32.79%
(FY 2022)
- Profit 623.95%
(FY 2022)
- Ebitda 63.97%
(FY 2022)
- Net Worth 59.10%
(FY 2022)
- Total Assets 287.83%
(FY 2022)
About Benedic Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹1.54 Cr.
Piyush Arora, Indu Batra, and Shantanu Virmani serve as directors at the Company.
- CIN/LLPIN
U51909UR2016PTC001952
- Company No.
001952
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Benedic Pharmaceuticals Private Limited offer?
Benedic Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Pain Relief Oil, Anti Infective Drugs & Medicines, Antibacterial Drugs, Vitamin Tablets & Capsules, Vitamin C Tablets & Capsules, Common Disease Medicines, Antihistamines, Pharmaceutical Syrup, Respiratory System Drugs.
Who are the key members and board of directors at Benedic Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Arora  | Director | 14-Mar-2016 | Current |
| Indu Batra | Director | 14-Mar-2016 | Current |
| Shantanu Virmani | Director | 14-Mar-2016 | Current |
Financial Performance of Benedic Pharmaceuticals.
Benedic Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.79% increase. The company also saw a substantial improvement in profitability, with a 623.95% increase in profit. The company's net worth Soared by an impressive increase of 59.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Benedic Pharmaceuticals?
In 2020, Benedic Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zaneka Pharmaceuticals Private LimitedActive 25 years 7 monthsIndu Batra and Shantanu Virmani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Jan 2024 | ₹1.44 M | Open |
Hdfc Bank Limited Creation Date: 17 Jul 2022 | ₹1.20 Cr | Open |
Hdfc Bank Limited Creation Date: 27 Apr 2022 | ₹2.01 M | Open |
How Many Employees Work at Benedic Pharmaceuticals?
Unlock and access historical data on people associated with Benedic Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Benedic Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Benedic Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
